Aerosol Delivery Devices Market by Product (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Non-Respiratory Diseases), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-commerce): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4059012
- 277 Pages
- August 2020
- Healthcare
Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and non-respiratory diseases. There are different forms of drugs available for aerosol drug delivery such as dry powder, solution, and suspension. It is the most advanced mode of drug administration in which aerosolized drug is directly delivered to lungs to offer a systemic effect. Aerosol delivery devices are available in three types, namely, dry powder inhalers, metered dose inhalers, and nebulizers. Aerosol drug delivery is a natural therapy and easiest way to treat respiratory diseases such as asthma, COPD, and cystic fibrosis. Moreover, it is used to deliver insulin, analgesic medications, and other drugs as well.
Rise in prevalence of asthma, COPD, and other respiratory disorders, increase in smoking population, ease of administration of drug with aerosol delivery devices, rise in demand for metered-dose inhalers, technological advancements in inhaler devices, and rise in geriatric population are the key factors that fuel growth of the global aerosol delivery devices market. For instance, according to the WHO, in 2018, more than 339 million people were affected by asthma worldwide. Moreover, rise in adoption of aerosol delivery devices by patients, increase in patient awareness toward inhalation therapy, surge in preference of pulmonary route of drug delivery, rise in urbanization and pollution levels, increase in incidences of preterm births and lifestyle changes, and increase in number of R&D activities to develop ideal inhalation therapy are other factors that contribute toward growth of the market. However, complications and side-effects associated with drug inhalation and high cost associated with nebulizers are expected to hinder growth of the market.
The global aerosol delivery devices market is segmented into product, application, and distribution channel. By product, the market is categorized into dry powder inhalers, metered dose inhalers, and nebulizers. The dry powder inhalers segment is further bifurcated into single dose inhalers and multi dose inhalers. The metered dose inhalers segment is further divided into conventional pressurized inhalers and soft mist inhalers. The nebulizers segment is further categorized into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. On the basis of application, the market is segregated into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases. The non-respiratory diseases segment is further divided is into diabetes, analgesia, and Parkinson’s disease. Depending on distribution channel, the market is classified into retail pharmacies, hospital pharmacies, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
• Dry powder inhalers
o Single dose inhalers
o Multi dose inhalers
• Metered dose inhalers
o Conventional pressurized inhalers,
o Soft mist inhalers
• Nebulizers
o Jet nebulizers
o Ultrasonic wave nebulizers
o Vibrating mesh nebulizers
By Application
• Asthma
• Chronic obstructive pulmonary disease
• Cystic fibrosis
• Non respiratory diseases
o Diabetes
o Analgesia
o Parkinson’s disease
By Distribution Channel
• Retail pharmacies
• Hospital pharmacies
• E-commerce
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• 3M Company
• Aerogen, Inc.
• Glaxosmithkline Plc (GSK)
• Johnson & Johnson (Actelion Pharmaceuticals Ltd)
• Koninklijke Philips N.V.
• Merck & Co. Inc.
• Metall Zug Group (Clement Clarke International Ltd)
• Recipharm AB (Bespak)
• Teva Pharmaceutical Industries Limited
• Vectura Group Plc
• Gerresheimer AG
• Heitkamp & Thumann KG (H&T Presspart)
• Iconovo AB
• Merxin Ltd
• Nemera
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• AstraZeneca Plc
• Boehringer Ingelheim GmbH
• Novartis AG
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in air pollution
3.5.1.2.Advantages over conventional drug delivery devices
3.5.1.3.Increase in prevalence of COPD and asthma
3.5.1.4.Rise in government initiatives
3.5.2.Restraint
3.5.2.1.High cost of asthma and COPD treatments
3.5.2.2.Lack of access in underdeveloped countries
3.5.3.Opportunity
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Pricing analysis of aerosol delivery devices
3.7.Covid-19 Impact analysis on aerosol delivery devices market
3.8.Top manufacturers list by region
3.9.Product pipeline analysis
3.10.License terms information
3.11.Qualitative information on mass median aerodynamic diameter (MMAD)
3.12.Regulatory Information for U.S., Europe, Japan, and China: aerosol delivery sevices
3.13.Innovations in aerosol delivery devices market
CHAPTER 4:AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Dry powder inhalers (DPIs)
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Single dose inhalers
4.2.5.1.Market size and forecast
4.2.6.Multi dose inhalers
4.2.6.1.Market size and forecast
4.2.7.Market size and forecast, by application
4.3.Metered dose inhalers (MDIs)
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.5.Conventional pressurized inhalers
4.3.5.1.Market size and forecast
4.3.6.Soft mist inhalers
4.3.6.1.Market size and forecast
4.3.7.Market size and forecast, by application
4.4.Nebulizers
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.5.Jet nebulizers
4.4.5.1.Market size and forecast
4.4.6.Ultrasonic wave nebulizers
4.4.6.1.Market size and forecast
4.4.7.Vibrating mesh nebulizers
4.4.7.1.Market size and forecast
4.4.8.Market size and forecast, by application
CHAPTER 5:AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Asthma
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Chronic obstructive pulmonary disease (COPD)
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Cystic fibrosis
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Non-respiratory diseases
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.5.3.Market size and forecast, by type
5.5.4.Diabetes
5.5.4.1.Market size and forecast
5.5.5.Analgesia
5.5.5.1.Market size and forecast
5.5.6.Parkinson's disease
5.5.6.1.Market size and forecast
CHAPTER 6:AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Retail pharmacies
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Hospital pharmacies
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.E-commerce
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:AEROSOL DELIVERY DEVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. aerosol delivery devices market, by product
7.2.2.1.2.U.S. aerosol delivery devices market, by application
7.2.2.1.3.U.S. aerosol delivery devices market, by distribution channel
7.2.2.2.Canada
7.2.2.2.1.Canada aerosol delivery devices market, by product
7.2.2.2.2.Canada aerosol delivery devices market, by application
7.2.2.2.3.Canada aerosol delivery devices market, by distribution channel
7.2.2.3.Mexico
7.2.2.3.1.Mexico aerosol delivery devices market, by product
7.2.2.3.2.Mexico aerosol delivery devices market, by application
7.2.2.3.3.Mexico aerosol delivery devices market, by distribution channel
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by distribution channel
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany aerosol delivery devices market, by product
7.3.2.1.2.Germany aerosol delivery devices market, by application
7.3.2.1.3.Germany aerosol delivery devices market, by distribution channel
7.3.2.2.France
7.3.2.2.1.France aerosol delivery devices market, by product
7.3.2.2.2.France aerosol delivery devices market, by application
7.3.2.2.3.France aerosol delivery devices market, by distribution channel
7.3.2.3.UK
7.3.2.3.1.UK aerosol delivery devices market, by product
7.3.2.3.2.UK aerosol delivery devices market, by application
7.3.2.3.3.UK aerosol delivery devices market, by distribution channel
7.3.2.4.Italy
7.3.2.4.1.Italy aerosol delivery devices market, by product
7.3.2.4.2.Italy aerosol delivery devices market, by application
7.3.2.4.3.Italy aerosol delivery devices market, by distribution channel
7.3.2.5.Spain
7.3.2.5.1.Spain aerosol delivery devices market, by product
7.3.2.5.2.Spain aerosol delivery devices market, by application
7.3.2.5.3.Spain aerosol delivery devices market, by distribution channel
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe aerosol delivery devices market, by product
7.3.2.6.2.Rest of Europe aerosol delivery devices market, by application
7.3.2.6.3.Rest of Europe aerosol delivery devices market, by distribution channel
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by distribution channel
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan aerosol delivery devices market, by product
7.4.2.1.2.Japan aerosol delivery devices market, by application
7.4.2.1.3.Japan aerosol delivery devices market, by distribution channel
7.4.2.2.China
7.4.2.2.1.China aerosol delivery devices market, by product
7.4.2.2.2.China aerosol delivery devices market, by application
7.4.2.2.3.China aerosol delivery devices market, by distribution channel
7.4.2.3.Australia
7.4.2.3.1.Australia aerosol delivery devices market, by product
7.4.2.3.2.Australia aerosol delivery devices market, by application
7.4.2.3.3.Australia aerosol delivery devices market, by distribution channel
7.4.2.4.India
7.4.2.4.1.India aerosol delivery devices market, by product
7.4.2.4.2.India aerosol delivery devices market, by application
7.4.2.4.3.India aerosol delivery devices market, by distribution channel
7.4.2.5.South Korea
7.4.2.5.1.South Korea aerosol delivery devices market, by product
7.4.2.5.2.South Korea aerosol delivery devices market, by application
7.4.2.5.3.South Korea aerosol delivery devices market, by distribution channel
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific aerosol delivery devices market, by product
7.4.2.6.2.Rest of Asia-Pacific aerosol delivery devices market, by application
7.4.2.6.3.Rest of Asia-Pacific aerosol delivery devices market, by distribution channel
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by distribution channel
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil aerosol delivery devices market, by product
7.5.2.1.2.Brazil aerosol delivery devices market, by application
7.5.2.1.3.Brazil aerosol delivery devices market, by distribution channel
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia aerosol delivery devices market, by product
7.5.2.2.2.Saudi Arabia aerosol delivery devices market, by application
7.5.2.2.3.Saudi Arabia aerosol delivery devices market, by distribution channel
7.5.2.3.South Africa
7.5.2.3.1.South Africa aerosol delivery devices market, by product
7.5.2.3.2.South Africa aerosol delivery devices market, by application
7.5.2.3.3.South Africa aerosol delivery devices market, by distribution channel
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA aerosol delivery devices market, by product
7.5.2.4.2.Rest of LAMEA aerosol delivery devices market, by application
7.5.2.4.3.Rest of LAMEA aerosol delivery devices market, by distribution channel
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by distribution channel
CHAPTER 8:COMPANY PROFILES
8.1.3M COMPANY
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.AEROGEN, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.3.GLAXOSMITHKLINE PLC (GSK)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.JOHNSON & JOHNSON (ACTELION PHARMACEUTICALS LTD)
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.KONINKLIJKE PHILIPS N.V.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.MERCK & CO., INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.METALL ZUG GROUP (CLEMENT CLARKE INTERNATIONAL LTD)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.RECIPHARM AB (BESPAK)
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.TEVA PHARMACEUTICAL INDUSTRIES LIMITED
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.VECTURA GROUP PLC
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
CHAPTER 9:APPLICATION BASED COMPANY PROFILES
9.1.GERRESHEIMER AG
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.HEITKAMP & THUMANN KG (H&T PRESSPART)
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.3.ICONOVO AB
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments
9.4.MERXIN LTD
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.5.NEMERA
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
TABLE 01.AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 04.DRY POWDER INHALERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 05.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 07.METERED DOSE INHALERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 08.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 10.NEBULIZERS AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 11.AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 12.ASTHMA AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.CHRONIC OBSTRUCTIVE PULMONARY DISEASE AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.CYSTIC FIBROSIS AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NON-RESPIRATORY DISEASES AEROSOL DELIVERY DEVICES MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 17.AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 18.RETAIL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 19.HOSPITAL PHARMACIES AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.E-COMMERCE AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 21.AEROSOL DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.U.S. AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 24.U.S. AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 25.U.S. AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 26.CANADA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 27.CANADA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 28.CANADA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 29.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 30.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 31.MEXICO AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 32.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 33.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 34.NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 35.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 36.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 37.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 38.GERMANY AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 39.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 40.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 41.FRANCE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 42.UK AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 43.UK AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 44.UK AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 45.ITALY AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 46.ITALY AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 47.ITALY AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 48.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 49.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 50.SPAIN AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 51.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 52.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 53.REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 54.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 55.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 56.EUROPE AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 57.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 58.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 59.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 60.JAPAN AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 61.CHINA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 62.CHINA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 63.CHINA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 64.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 65.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 66.AUSTRALIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 67.INDIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 68.INDIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 69.INDIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 70.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 71.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 72.SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 73.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 74.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 75.REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 76.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 77.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 78.ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 79.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 80.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 81.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 82.BRAZIL AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 83.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 84.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 85.SAUDI ARABIA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 86.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 87.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 88.SOUTH AFRICA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 89.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 90.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 91.REST OF LAMEA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 92.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, 2019–2027
TABLE 93.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, 2019–2027
TABLE 94.LAMEA AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019–2027
TABLE 95.3M: COMPANY SNAPSHOT
TABLE 96.3M: OPERATING SEGMENTS
TABLE 97.3M: PRODUCT PORTFOLIO
TABLE 98.AEROGEN: COMPANY SNAPSHOT
TABLE 99.AEROGEN: PRODUCT PORTFOLIO
TABLE 100.GSK: COMPANY SNAPSHOT
TABLE 101.GLAXOSMITHKLINE PLC: OERATING SEGMENT
TABLE 102.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 103.J&J: COMPANY SNAPSHOT
TABLE 104.J&J: OPERATING SEGMENTS
TABLE 105.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 106.J&J: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.PHILIPS: COMPANY SNAPSHOT
TABLE 108.PHILIPS: OERATING SEGMENT
TABLE 109.PHILIPS: PRODUCT PORTFOLIO
TABLE 110.PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.MERCK & CO., INC.: COMPANY SNAPSHOT
TABLE 112.MERCK & CO., INC.: OPERATING SEGMENTS
TABLE 113.MERCK & CO., INC.: PRODUCT PORTFOLIO
TABLE 114.METALL ZUG: COMPANY SNAPSHOT
TABLE 115.METALL ZUG: OERATING SEGMENT
TABLE 116.METALL ZUG: PRODUCT PORTFOLIO
TABLE 117.RECIPHARM: COMPANY SNAPSHOT
TABLE 118.RECIPHARM: OERATING SEGMENT
TABLE 119.RECIPHARM: PRODUCT PORTFOLIO
TABLE 120.RECIPHARM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.TEVA: COMPANY SNAPSHOT
TABLE 122.TEVA: PRODUCT PORTFOLIO
TABLE 123.TEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.VECTURA: COMPANY SNAPSHOT
TABLE 125.VECTURA: PRODUCT PORTFOLIO
TABLE 126.VECTURA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.GERRESHEIMER: COMPANY SNAPSHOT
TABLE 128.GERRESHEIMER: OERATING SEGMENT
TABLE 129.GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 130.HEITKAMP & THUMANN: COMPANY SNAPSHOT
TABLE 131.HEITKAMP & THUMANN: OERATING SEGMENT
TABLE 132.HEITKAMP & THUMANN.: PRODUCT PORTFOLIO
TABLE 133.ICONOVO: COMPANY SNAPSHOT
TABLE 134.ICONOVO: PRODUCT PORTFOLIO
TABLE 135.ICONOVO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.MERXIN: COMPANY SNAPSHOT
TABLE 137.MERXIN.: PRODUCT PORTFOLIO
TABLE 138.NEMARA: COMPANY SNAPSHOT
TABLE 139.NEMARA.: PRODUCT PORTFOLIO
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
